AR and prostate cancer: In acute myelocytic leukemia, esophageal squamous cell carcinomas, lung adenocarcinomas, thyroid carcinoma, prostate cancer, and AR-positive molecular apocrine breast cancer [12,23-25], FOXA1 acts as an oncogene.